Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

PRP treatment improved skin pigmentation and appearance in facial lichen planus pigmentosus.

Microorganism overgrowth and hyperkeratosis may trigger immune reactions causing lichen planopilaris.

This type of hair loss is probably often missed and treatments reducing inflammation might work well.

Linear lichen planopilaris can affect the trunk, not just the face.

Lichen planus pigmentosus may indicate undetected hepatitis C infection.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Dermoscopy is useful for diagnosing lichen planopilaris and certain features may relate to disease duration, age, and gender.

Abrocitinib may effectively treat Lichen Planopilaris.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Lichen planus is not linked to metabolic syndrome, but it is associated with higher rates of high blood pressure, high triglycerides, and low HDL cholesterol.

COX-2 and Bcl-2 proteins are involved in Lichen Planus.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Flexural follicular lichen planus is a rare skin condition affecting body folds.

A woman with lupus had unusual symptoms like blisters, skin inflammation, and throat ulcers, which improved with steroid and dapsone treatment.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Early diagnosis and treatment of Lichen Planopilaris are crucial to prevent permanent hair loss.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

LC-OCT is an effective new method for diagnosing classic lichen planopilaris.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Frontal fibrosing alopecia can occur with lichen planus pigmentosus, needing careful diagnosis and treatment.

Men with lichen planopilaris had earlier onset than women, and treatment usually improved the condition.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

Lichen planus may be associated with a higher risk of metabolic syndrome.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Lichen planus is linked to several autoimmune diseases.